Pallavi Bassi

Dr. Pallavi Bassi

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2010 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
PBPallavi Bassi
Pallavi Bassi
GKGurpreet Kaur
Gurpreet Kaur
In formulation development, weakly acidic or basic drugs pose a major challenge as the solubility depends significantly on pH of the dissolution media. This gives rise to pH-dependent drug release, as the formulation is exposed to different pH ranges in the gastrointestinal tract. This indicates a need to carry out formulation optimization for such drugs while developing them into a dosage form. For overcoming pH-dependent behavior of drugs, pH-modifying excipients (which alter the microenvironment pH inside the formulation) are most commonly used. A combination of enteric and sustained release polymers can be used for weakly basic drugs. Other strategies include conversion of crystalline drug to amorphous form, enhancement of partitioning of unionized fraction of drug from the formulation, and using a combination of pH modifier and enteric polymer, micellar solubilization and inclusion complexation. Readers will gain an insight into various formulation techniques for obtaining pH-independent drug release for weakly acidic and basic drugs. Readers will be able to evaluate the different formulation strategies in terms of their applicability and best use of the available strategies when designing their own research work for such drugs.

17 September 2023 in Carbohydrate Polymer Technologies and Applications
Verified
Journal Article
Open access
SKSamridhi Kurl
Samridhi Kurl
AKAman Kumar
Aman Kumar
REReena
Reena
NMN. Mittal
N. Mittal
DSDeepinder Singh
Deepinder Singh
GKGurpreet Kaur
Gurpreet Kaur

4 September 2024 in Polymers
Verified
Journal Article
Open access
PDF file
JSJangjeet Karan Singh
Jangjeet Karan Singh
SKSIMRAN KAUR
SIMRAN KAUR
BCBalakumar Chandrasekaran
Balakumar Chandrasekaran
GKGurpreet Kaur
Gurpreet Kaur
BSBalraj Saini
Balraj Saini
PBPallavi Bassi
Pallavi Bassi
The current study focuses on development of phospholipid complex-loaded films of etodolac for enhanced transdermal permeation and anti-inflammatory effect. An etodolac–phospholipid complex was developed using the solvent evaporation method and was characterized by DSC, XRD, FTIR, and 1H-NMR studies. The formation of the complex led to conversion of a crystalline drug to an amorphous form. A stoichiometric ratio of 1:1 (drug–phospholipid) was selected as the optimized ratio. Further, the developed complex was incorporated into films and systematic optimization using a central composite design was carried out using a response surface methodological approach. The desirable design space based on minimum contact angle and maximum tensile strength was selected, while the water vapour transmission rate and swelling index were set within limits. The results for swelling index, contact angle, tensile strength, and water vapour transmission rate were 60.14 ± 1.01%, 31.6 ± 0.03, 2.44 ± 0.39 kg/cm2, and 15.38 g/hm2, respectively. These values exhibited a good correlation with the model-predicted values. The optimized formulation exhibited improved diffusion and permeation across skin. In vivo studies revealed enhanced anti-inflammatory potential of the developed films in comparison to the un-complexed drug. Hence, the study demonstrated that etodolac–phospholipid complex-loaded films improve the transdermal permeation and provided enhanced anti-inflammatory effect.

1 May 2013
Verified
Journal Article
Closed access
HKHarpreet Kaur
Harpreet Kaur
PBPallavi Bassi
Pallavi Bassi
TMTausif Monif
Tausif Monif
AKArshad Khuroo
Arshad Khuroo
GKGurpreet Kaur
Gurpreet Kaur

1 July 2025 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
GTGopal Thakur
Gopal Thakur
PBPallavi Bassi
Pallavi Bassi
KGKritika Garg
Kritika Garg
NKNeha Kumari
Neha Kumari
For years, oral administration of drug has been prioritized because of its ease and patient compliance. However, there are some drawbacks which comes with this delivery system out of which the main concern is first pass metabolism which affect the bioavailability of drugs. So, to improve the bioavailability and avoid first pass metabolism intravenous (IV) delivery would be the best option but it is often painful and can’t be used by patient by their own. Transdermal drug delivery systems (TDDS) may overcome these issues by giving the drug via skin but it is challenging because of the startum corneum. Hence to shortout all these issues some investigations are being carried out by the researchers which include vesicle delivery, iontophoresis, electroporation, sonophoresis, and microneedle methods. The ability of these methods to overcome all these problems have been concluded by the various studies. To make them more effective in future some advancements such as lipid polymer hybrid nanoparticles, targeted vesicles (by adhering ligands on vesicle surfaces), microneedles with sensors which regulate the drug flow and also dissolvable microneedles or alter in electrical and ultrasound parameters to minimize the tissue damage, may further enhance their effectiveness.

1 January 2024 in AIP Conference Proceedings
Verified
Conference Paper
Closed access
PDF file
NKNeha Kumari
Neha Kumari
PBPallavi Bassi
Pallavi Bassi
Functional food having great importance if we consume it on daily basis. Many disorders and chronic disease can prevent with the consumption of it. And probioti Functional food having great importance if we consume it on daily basis. Many disorders and chronic disease can prevent with the consumption of it. And probioti